Phase 2 Study of RSLV-132 in Subjects With Long COVID
Clinical trial NCT04944121 · COMPLETED
Trial details
- NCT number
- NCT04944121
- Sponsor
- Resolve Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-25
- Primary completion
- 2023-10-31
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.